Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQ4G1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $100,295
Award facts
- Contract value 100% obligated
- $100,294.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $100,294.95 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 23, 2025. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and is a critical vendor for military and veteran healthcare systems.
This delivery order supports DLA's pharmaceutical supply operations, which distribute medications to Defense Health Agency facilities, military personnel, and other federal healthcare beneficiaries. The contract leverages AmerisourceBergen's comprehensive global pharmaceutical prime vendor capabilities established under the SPE2DX IDC, enabling efficient delivery of brand-name and generic medications across multiple therapeutic domains. As a child contract under the larger IDC vehicle, this delivery order exemplifies the flexibility and efficiency of DLA's indefinite delivery contracting approach, which allows for rapid procurement of critical pharmaceutical commodities to support military healthcare requirements worldwide.
Quick answers
Who was awarded contract SPE2DB25FQ4G1?
SPE2DB25FQ4G1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FQ4G1 worth?
The government has obligated $100,295 on SPE2DB25FQ4G1.
Is contract SPE2DB25FQ4G1 an order under another contract?
Yes. SPE2DB25FQ4G1 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ4G1 competed?
The extent of competition for SPE2DB25FQ4G1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award